ALPHAGENIX Trademark

Trademark Overview


On Thursday, April 16, 2009, a trademark application was filed for ALPHAGENIX with the United States Patent and Trademark Office. The USPTO has given the ALPHAGENIX trademark a serial number of 77715882. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 28, 2010. This trademark is owned by AlphaGenix, Inc.. The ALPHAGENIX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polypeptides for in vitro research use; Biological Tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Cells for scientific, laboratory or medical research; Chemical preparations for scientific purposes; Chemicals for use in biotechnological product development; Chemicals for use in the biochemical and chemical industry; Diagnostic kits consisting primarily of monoclonal antibodies, buffer...

Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatm...

(Based on Use in Commerce) Biological research; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Genetic mapping for scientific purposes; Genetic testing of laboratory animals for research purposes; Medical and scientific research services in the field of cancer treatment and diagnosis; Medical research; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of biomaterials; Research and development of vaccines and medicines; Scientific research and development; Scientific research in the field of genetics and genetic engineering(Based on Intent to Use)...
alphagenix

General Information


Serial Number77715882
Word MarkALPHAGENIX
Filing DateThursday, April 16, 2009
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, January 28, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedThe color(s) gold, orange, blue, green, gray, white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of The word "AlphaGenix" placed to the left of a double strand of DNA originating from a biological cell.
Goods and ServicesBiochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polypeptides for in vitro research use; Biological Tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Cells for scientific, laboratory or medical research; Chemical preparations for scientific purposes; Chemicals for use in biotechnological product development; Chemicals for use in the biochemical and chemical industry; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Kit comprising of regeneration solution, serum samples and sensor chips for scientific use.; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Protein arrays and nucleotide arrays for scientific and medical research; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Stem cells for research or scientific purposes; Stem cells for research purposes; Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substances; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
Goods and ServicesDiagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma
Goods and Services(Based on Use in Commerce) Biological research; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Genetic mapping for scientific purposes; Genetic testing of laboratory animals for research purposes; Medical and scientific research services in the field of cancer treatment and diagnosis; Medical research; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of biomaterials; Research and development of vaccines and medicines; Scientific research and development; Scientific research in the field of genetics and genetic engineering(Based on Intent to Use) Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Basic and clinical research in the field of respiratory science and medicine
Pseudo MarkALPHA GENIX

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, April 21, 2009
Primary Code001
First Use Anywhere DateThursday, July 26, 2007
First Use In Commerce DateThursday, July 26, 2007

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 21, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 21, 2009
Primary Code042
First Use Anywhere DateThursday, July 26, 2007
First Use In Commerce DateThursday, July 26, 2007

Trademark Owner History


Party NameAlphaGenix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSioux Falls, SD 57107

Trademark Events


Event DateEvent Description
Thursday, January 28, 2010ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, January 28, 2010ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 2, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 2, 2009NON-FINAL ACTION E-MAILED
Thursday, July 2, 2009NON-FINAL ACTION WRITTEN
Wednesday, July 1, 2009ASSIGNED TO EXAMINER
Wednesday, April 22, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, April 21, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 20, 2009NEW APPLICATION ENTERED IN TRAM